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Abstract
The role of the autonomic nervous system (ANS) was recently investigated in Temporomandibular disorders (TMD). Several
authors argue that in subjects with TMD there is a dysregulation of ANS. Recent literature support that Pupillometry is
a simple non-invasive tool to study ANS. The aim of this study was to investigate the relationship between TMD and ANS
activity using pupillometry recording in Infrared light at rest Mandible Position (RP); Infrared light at Forced Habitual
Occlusion (FHO); Yellow-green light at RP; Yellow-green light at FHO. Forty female subjects were enrolled: 20 case patients
showed TMD based on the Research Diagnostic Criteria for TMD, and 20 control patients, aged matched, had no signs or
symptoms of TMD. Statistical analysis was performed on average pupil size. Ratio between pupil size in FHO and RP (FHO/RP
ratio) and yellow-green and infrared (light/darkness ratio) lighting were carried out. Within group differences of pupil size
and of ‘‘ratio’’ were analyzed using a paired t test, while differences of pupil size between groups were tested using an
unpaired t test. Statistical comparisons between groups showed no significant differences of absolute values of pupil
dimension in RP and FHO, both in yellow-green and in infrared lighting. In addition, there were no significant differences
within groups comparing RP and FHO in yellow-green light. In within group comparison of pupil size, differences between
RP and FHO were significant in infrared conditions. Control subjects increased, whereas TMD patients decreased pupil size
at FHO in infrared lightening. FHO/RP ratio in darkness and light/darkness ratio in RP were significantly different between
groups. Taken together, these data suggest that TMD subjects have an impairment of the sympathetic-adrenergic
component of the ANS to be activated under stress. The present study provides preliminary pupillometric data confirming
that adrenergic function is dysregulated in patients with TMD.
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Introduction
The role of the autonomic nervous system (ANS) was recently
investigated in Temporomandibular Disorders (TMD). Several
authors argue that in subjects with TMD there is a dysregulation
of ANS [1,2,3]. Such a dysregulation is in part based on genetics
[4]. It implies that the patients’ enhanced sympathetic drive
inhibites normal catecholamine release resulting in significant
effects on peripheral target organs and functions of the ANS,
which would become less efficient in adapting to the needs of
environmental and physiologic demands [5].
Some authors demonstrated the influence of the sympathetic
branch of ANS on the muscles and dynamics of the jaw in animals
and humans [6,7,8,9,10].
The control of contraction and dilation of the pupil is due to the
sympathetic nerve centers (Budge’s ciliospinalis centre) and
parasympathetic centre (Edinger- Wesphal Nucleus). The first
promotes the pupil dilation (mydriasis), the second the constriction
(miosis) according to the light stimulation.
Pupillometry is a simple and non-invasive tool to assess the size
of the pupil. It is considered a reliable tool in the study of pupil
effects of drugs [11,12,13] and literature supports that it is a valid
method to study the ANS [14].
Pupil diameter significantly correlated with heart rate variability
[15] and showed its usefulness for assessing the ANS dysregulation
in clinical conditions in which the ANS is involved
[16,17,18,19,20,21].
The aim of this work is to study the effect of light condition and
of dental occlusion on ANS behavior through the study of the
pupil in subjects with TMD. The hypothesis is that these subjects
exhibit a reduced ability to adapt and are less able than control
subjects to modify the response of the pupil to activation induced
by occlusal and light variations.
Materials and Methods
Subjects
This study was conducted in accordance with the Declaration of
Helsinki. The Committee on Ethics in Science of the University of
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L’Aquila, L’Aquila, Italy approved the study and informed consent
was obtained from each subject.
Inclusion/Exclusion Criteria
20 patients that fulfilled the following criteria were included in
the study: age less than 30 years; female gender; presence of
complete permanent dentition, with the possible exception of the
third molars; normal occlusion; and diagnosis of unilateral
arthrogenous TMD, based on the Research Diagnostic Criteria
for TMD (RDC/TMD) [22] Axis I, groups II and III in remission
at least from 3 months.
Patients were excluded from the study if they met one or more
of the following criteria: having systemic or metabolic diseases; eye
diseases or visual defects; history of local or general trauma;
neurological or psychiatric disorders; muscular diseases; cervical
pain; bruxism, diagnosed by the presence of parafunctional facets
and/or anamnesis of parafunctional tooth clenching and/or
grinding; pregnancy; assumption of anti-inflammatory, analgesic,
anti-depressant, opioid or myorelaxant drugs; smoking; fixed or
removable prostheses; fixed restorations that affected the occlusal
surfaces; either previous or concurrent orthodontic or orthog-
nathic treatment.
Control Group consisted of 20 young women scheduled for
a routine checkup at University Clinic, aged matched, without
signs or symptoms of TMD, who fulfilled the inclusion and
exclusion criteria.
Pupillometry
Pupillometry was performed with a table-mounted infrared
pupillometer (Oculus system, Inventis srl, Padova, Italy), which is
composed by two infrared CCD cameras (resolution of 7206576
pixels, 256 grey levels) mounted on a light helmet (1.5 kg), with
sampling frequency of 25 frame/s. To stabilize accommodation,
the subjects were asked to focus their eyes on the light point into
the pupillometer [23]. Assessment of pupil size was performed in
light conditions, illuminating the eyes with a yellow-green led with
740 nanometer of wave-length, and under dark conditions that
were obtained with an infrared diode with 880 nanometer of
wave-length.
Pupillometric recordings were acquired in digital form and
processed through the algorithm of Tarjan (of strongly connected
components) [24] to measure frame by frame the area of pupil,
expressed as number of pixels. A template was positioned on the
computer screen allowing to correct the position of the eyes to
avoid errors due to different positions of the pupil.
Pupillometry was performed with the subjects in horizontal
supine position, on a bed for clinical examination. Room
temperature (21uC) and relative humidity (50%) were maintained
constant. Any external or internal source of noise was excluded.
Before any pupillometric recording session, patients were invited
to lie on an examining table with open eyes for at least 3 minutes,
to adapt to the temperature and humidity of the room, as well to
reduce the anxiety status. Then the pupillometer was applied and
maintained until the end of the recording session.
Recording Procedure
The subjects underwent to 4 subsequent recordings of 30 s
each:
1. Infrared light at Rest Mandible Position (RP);
2. Infrared light at Forced Habitual Occlusion (FHO);
3. Yellow-green light at RP;
4. Yellow-green light at FHO.
The sequence of tests was assigned randomly. At the end of each
test, a period of 1 minute followed in which subjects were asked to
stay with eyes closed. Each new acquisition started 15 seconds
after the opening of the eyes.
FHO was standardized by surface electromyography (SEMG).
Disposable electrodes (Duotrode, bipolar surface electrodes Ag-
AgCl, 20 mm center to center distance, Myotronics-Noromed,
Inc., Tukwila WA, USA) were used for SEMG recording on right
and left masseter. The electrodes were connected to SEMG
equipment (K7/EMG, Myotronics-Noromed, Inc., Tukwila WA,
USA). A pretest established, for each subject, the value of SEMG
amplitude (Averaging) corresponding to maximum voluntary
clenching. During FHO tests, SEMG values were maintained
with verbal instructions from the operator between 30 and 50% of
the maximum voluntary clenching.
Statistical Analysis
Statistical analysis was performed using STATA 10 (StataCorp
LP, College Station, TX, USA) on average pupil size, computed
on 30 seconds of recording. Ratio between pupil size in FHO and
RP (referred to as FHO/RP ratio in the following) and yellow-
green and infrared (light/darkness ratio) lighting were carried out.
Shapiro-Wilk test revealed normal distribution of data. Within
group differences of pupil size and of ‘‘ratio’’ were analyzed using
a paired t test, while differences of pupil size between groups were
tested using an unpaired t test. The level of significance was set at
p,0.01 for all tests. Results are expressed as mean and standard
deviation.
Results
Statistical comparisons between groups showed no significant
differences of absolute values of pupil dimension in RP and FHO,
both in yellow-green and in infrared lighting. In addition, there
were no significant differences within groups comparing RP and
FHO in yellow-green light.
In within group comparison of pupil size, differences between
RP and FHO were significant in infrared conditions. In
particular, in Control Group, pupil had significantly larger size
(p = 0.005) in FHO compared to RP, while in TMD group the
size of pupil was significantly lower (p = 0.009) in FHO
compared to RP (Table 1).
FHO/RP ratio did not present significant differences in yellow-
green light conditions in between groups comparison, whereas in
infrared light condition the comparison between groups showed
a highly significant difference (p = 0.0006) with a larger ratio in
Control Group (1.055) compared to TMDGroup (0.967) (Table 2).
Light/darkness ratio showed a high significance (p = 0.0008) in
the comparison between Control Group (0.662) and TMD Group
(0.486) at RP, while there was no significant difference between
the two groups at FHO (Table 3).
Figures 1 and 2 show box plots of the distribution of FHO/RP
ratio in infrared light and light/darkness ratio at RP.
Discussion
The present study provides preliminary pupillometric data
confirming ANS dysregulation in TMD patients.
In particular it should be noted that: a) TMD patients show
values of pupil size greater in RP infrared and lower in RP light
condition than control subjects, although not statistically signifi-
cant; b) under stress condition (light-FHO) TMD subjects behave
differently compared to control subjects: FHO/RP ratio in
darkness and light/darkness ratio in RP have significantly different
Pupillometric Study in Temporomandibular Disorder
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behavior in the two groups. Control subjects increased, whereas
TMD patients decreased pupil size at FHO in infrared lightening.
In infrared conditions FHO/RP ratio is significantly greater in
Control Group as well as light/darkness ratio at RP.
Pupil size in RP infrared is greater in control than in TMD
group. The comparison between groups does not indicate
statistical significance, probably because of dispersion of values.
On the other hand, comparison within group at infrared
lighting shows that FHO pupil size of the control subjects increases
significantly compared to RP, while FHO pupil size of TMD
subjects decreases significantly.
Difference of pupil behavior between groups, highlighted by
the ratio between the two different conditions (FHO/RP),
becomes significant because in control group it is directed
toward a ratio greater than 1 (1.055) for the increase of the size
in FHO respect to RP, while in the TMD group it is directed
toward a ratio less than 1 (0.967) for the reduction of the size in
FHO compared to RP.
Homogeneous behavior of FHO/RP ratio within group was
highlighted by the low standard deviation, especially in FHO
infrared condition (0.0734 in control group and 0,037 in TMD
group).
Similar argument can be made for RP light/darkness ratio
higher in control than TMD subjects. In RP infrared, as above
discussed, the pupil size is lower, although not significantly, in
control compared to TMD subject (7680.72 vs 8412.75), while in
RP yellow-green light the pupil size is greater in control than in
TMD subjects (4835.38 vs 4289.51).
As a speculative, it can be suggested that TMD subjects show
a greater activation or less inhibition of iris muscles contraction
under conditions of specific stimulation (presence or absence of
light) and less activation or greater inhibition of the contraction
under generic stimulation (FHO).
In any case, certain degree of dysregulation would occur
between the two branches of ANS, suggesting that TMD subjects
could suffer from impairment to be activated under stress.
Pupil size is controlled by complex interaction between
sympathetic and parasympathetic branches of ANS: the first uses
mainly adrenergic, the second cholinergic pathway.
Both muscles of iris (sphincter and dilator) receive reciprocal
innervations from the 2 branches of ANS providing contraction
and inhibition (or relaxation).
Parasympathetic cholinergic fibers, coming from Edinger-We-
sphal Nucleus, supply the iris sphincter acting for contraction of
the muscle and the consequent reduction of the pupil size. At the
same time, the sphincter receives beta-adrenergic innervations
able to reduce the contraction inducing relaxation of the muscle
[43,44]. In humans pupil dilation obtained by beta-adrenergic
inhibition of sphincter can be equal to 1/3 of the maximum
physiological dilation [45].
On the other hand, iris dilator muscle receives a predominant
adrenergic sympathetic motor innervation (Budge’s Cilio Spinal
Center) causing contraction and the consequent increase in pupil
size. Dilator muscle contraction is mediated by alpha-adrenergic
receptors and inhibition or relaxation may be exercised by
muscarinic receptors and, although not yet fully documented, by
beta-adrenergic innervations [46,47,48,49,50].
The consequence of dysregutated balance of reciprocal
innervations may lead to a deficit of inhibitory effect. Defect in
beta-adrenergic or muscarinic inhibition that counteracts the
action of alpha-adrenergic contraction of the dilator may result in
increased pupil size in darkness; at the same time, reduction of
beta-adrenergic inhibition on cholinergic system of sphincter
muscle could lead to increase of miosis.
Etiology of TMD remains somewhat uncertain. Some authors
have shifted the focus away from stomatognathic system and
occlusion suggesting that ANS could play a crucial role in
generating the main signs and symptoms of this disorder
[1,2,3,51].
Dysregulation of ANS and the phenomena associated with
chronic cortisol secretion [25,26] would be crucial in the
pathogenesis of TMD. Causes of TMD related to type of
occlusion or masticatory muscle hyperactivity did not give





RP in infrared light
condition
FHO in infrared light
condition
Control Group 4835.38 (1858.24) 4712.69 (1637.35) 7680.72 (2051.01) 8225.91* (1938.80)
TMD Group 4289.51 (1543.59) 4258.83 (1583.17) 8412.75 (1956.50) 8199.52** (1956.51)
t Test 0.21 0.24 0.18 0.48
In brackets the standard deviation. * Comparison between RP and FHO condition in infrared light within Control Group: p = 0.005. ** Comparison between RP and
infrared light in FHO condition within TMD Group: p = 0.009.
doi:10.1371/journal.pone.0045424.t001
Table 2. FHO and RP ratio in Control and TMD Group.
Yellow-green light Infrared light
FHO/RP ratio Control
Group
0.996 (0.149) 1.055 (0.073)
FHO/RP ratio TMD
Group
1.002 (0.169) 0.967 (0.037)
t Test 0.46 0.0006
Statistical comparison between the two groups. Significance level at p = 0.01. In
brackets the standard deviation.
doi:10.1371/journal.pone.0045424.t002




0.662 (.099) 0.545 (0.345)
Light/Darkness ratio TMD Group 0.486 (0.137) 0.510 (0.375)
t Test 0.0008 0.24
Comparison between Groups. Significance level at p = 0.01. In brackets the
standard deviation.
doi:10.1371/journal.pone.0045424.t003
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Figure 1. Box plot of FHO/RP ratio in infrared light condition.
doi:10.1371/journal.pone.0045424.g001
Figure 2. Box plot of Light/Darkness ratio in rest mandible position.
doi:10.1371/journal.pone.0045424.g002
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conclusive results. Beyond some partial results, occlusion or
muscular activity cannot be surely assumed at the base of TMD.
Muscles, however, could be called into question secondarily by
presence of ANS dysregulation with regard to coordination of
simple and complex functions [6,7,8,9,10].
On the other hand, some TMD symptoms can be reduced
significantly by pharmacological therapies aimed at improving the
sympathetic-adrenergic regulation. Beta-adrenergic system seems
to be particularly involved. TMD patients showed lower plasma
epinephrine (EPI) and norepinephrine (NE) levels than healthy
subjects [5]. Moreover, several studies have demonstrated the
effect of propranolol (sympatholytic non-selective beta blocker) on
clinical pain severity showing linear relationship between beta-
adrenergic dysregulation and pain reduction after propranolol
administration in genetic subgroup of TMD patients
[27,28,52,53].
Taken together, these works suggest that beta-adrenergic system
could be one of the key dysfunction associated with TMD pain
and its therapy.
As mentioned above, beta-adrenergic receptors could have an
inhibitory role on dilator and sphincter muscle. In dilator muscle
beta-adrenergic and muscarinic receptors could cooperate to
mediate relaxation counterbalancing pupil dilation; in sphincter
muscle beta-adrenergic receptors could counterbalance pupil
constriction.
Our data seem in agreement with above observations about
ANS dysregulation in TMD.
Beta-adrenergic system of iris muscles in TMD patients could
result in reduction or inhibition of the counterbalancing action on
alpha-adrenergic pupil dilation system; the effect could be the
increase of pupil size in darkness, whereas beta-adrenergic defect
on cholinergic sphincter contraction, determining reduction of
inhibitory effect, could result in greater miosis in yellow-green
lighting. The light/darkness ratio smaller in TMD subjects
compared with control group could be explained in the same way.
In control healthy group and in conditions of darkness, during
which the tonus of sympathetic system prevails, occlusal stress
produces a further increase of pupil size, whereas in TMD subjects
occlusal ‘‘stress’’ fails to obtain the same sympathetic activation.
TMD subjects showed within group significant reduction in pupil
size. It could be interpreted as a failure of the sympathetic response
to stress.
FHO can be compared to muscle exercise involving activation
of the sympathetic system and a simultaneous variation of the
pupil size [29,30]. Clenching, in fact, produces sympathetic
activation, partly via an increase of blood flow and pressure of
the head [31,32,33].
Accordingly, in our work the size of pupil increases during
clenching in control group showing ANS response to the increase
of the demand. In subjects with TMD this phenomenon is not
present. In these subjects, the size of pupil decreases. Effect of type
of dental occlusion on results could be excluded by strict inclusion
criteria.
On the other hand, in RP yellow-green lighting TMD subjects
show more accentuated reaction compared to control subjects.
TMD subjects’ pupil is smaller in light condition and is greater in
darkness than controls’ one. Consequently, the RP light/darkness
ratio is lower in TMD compared to control subjects. This could
also be in accordance with the above-discussed deficit of beta-
adrenergic inhibitory control of the iris sphincter muscle.
In general, pupil size reduction can be determined by light,
parasympathomimetics substances, relaxation and convergence of
the eyes. All mentioned phenomena have been checked through
the experimental set up and no substances (sympathetic or
parasympathomimetic) were taken by the subjects during the
experimental session.
The degree of relaxation could be different in control and TMD
subjects, in particular the latter may have difficulty to adapt to
experimental conditions in relation to psychological characteristics
described in literature [34,35,36].
Mood disorders, frequently related to TMD, involve dysregula-
tion of the sympathetic system [37,38,39,40,41]. Some evidences
stated that pupil diameter in the dark is not affected by anxiety but
responses to light stimuli in the anxious patient had consistently
lower amplitudes [42], suggesting a greater supranuclear in-
hibition of the parasympathetic oculomotor reflex arc in the
anxious patients.
In our work we studied tonic pupil behavior in constant
lightening (yellow-green and infrared) and we don’t have any
direct information about pupil reflex. For this reason it’s
impossible to compare our results (lower light/darkness ratio,
lower FHO/RP ratio in infrared light, lower pupil size in yellow-
green light, greater pupil size in darkness of TMD group)
apparently in disagreement with above cited [42,50] using light
reflex. Moreover, we didn’t use psychometric scales to measure
mood and psychological characteristics of subjects. We can’t
exclude psychological influence on our TMD and control sample.
Our data show altered tonic adjustments of ANS in TMD
patients. On the other hand, since the sequence of tests was
randomized it is unlikely that the effects observed in the study are
strictly related to environmental or emotional adaptation.
Of course, the interpretation of our results need more data, the
sample is too small to draw definitive conclusions. Our study used
pupillometry to monitor the activity of ANS without comparing
pupillometric data to other data coming from signals already used
in literature to study ANS (HRV, electrodermal activity, etc.).
Probably, this is one reason why we can only suggest a speculative
interpretation of data. Next work will be devoted to confirm what
suggested interfacing various signals and sampling specific
population, for example comparing TMD patients treated with
beta blockade drugs with untreated.
This work can be considered a pilot study. If confirmed, it could
provide a useful, rapid and noninvasive tool to test ANS behavior
in TMD patients, and to monitor the response to therapy quickly
and directly in dental office.
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